# Entero Healthcare Solutions Ltd (ENTERO)
> Exchange: NSE | Sector: Pharma | ISIN: INE010601016

## Price
Current Price: ₹1299.9
Day Change: +3.6%
52W High: ₹1510.8
52W Low: ₹944
Market Cap: ₹5,186 Cr

## Valuation
P/E: 46.07
P/B: 2.94
EPS: ₹25.87
Book Value: ₹405.79
Dividend Yield: 0%

## Returns
1Y Return: 9.61%

## Profitability
ROE: 0%
ROCE: 53.97%
Debt/Equity: 0.25
Revenue Growth: 25.6%
Profit Growth: 8.6%
EBITDA Margin: 3.36%
Operating Margin: 3.4%

## About
Entero Healthcare Solutions Ltd is a Medical Distribution company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Medical Distribution
Sub Industry: Unknown

## Business Model
Overview: Entero Healthcare Solutions Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Medical Distribution. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Announcement under Regulation 30 (LODR)-Scheme of Arrangement
- Announcement: Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- BSE Filing: Announcement under Regulation 30 (LODR)-Scheme of Arrangement

## Access
Current tier: anonymous
More history: Register free to see 3 more years.

## Data Freshness
Quote Updated: 2026-05-21T20:00:01.518Z
Price History Updated: 2026-05-18T22:58:36.626Z
Latest Price History Date: 2026-05-18
Technicals Updated: 2026-05-18T22:58:36.626Z
Quant Updated: 2026-05-18T22:58:36.626Z
Sentiment Updated: 2026-05-18T22:58:36.626Z
Financials Status: current
Financials Updated: 2026-05-18T13:30:10.405Z
Financials Last Attempt: 2026-05-18T13:30:10.405Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (Mar 2021)
Revenue: ₹1350 Cr
Operating Profit: ₹23 Cr (OPM 2%)
Net Profit: ₹1 Cr
Tax: ₹4 Cr

## Annual P&L History
Mar 2021: Rev ₹1350Cr | PAT ₹1Cr | OPM 2%
Mar 2022: Rev ₹1773Cr | PAT ₹-15Cr | OPM 1%
Mar 2023: Rev ₹2522Cr | PAT ₹-29Cr | OPM 1%

## Balance Sheet (Mar 2021)
Total Assets: ₹749 Cr
Total Liabilities: ₹749 Cr
Borrowings: ₹603 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Prabhat  Agrawal, Co-Founder, CEO, MD & Director
- Prem  Sethi, Co-Founder, COO & Whole-time Director
- Sanu Vishal Kapoor, VP of Legal and General Counsel, Company Secretary & Compliance Officer
- Balakrishnan Natesan Kaushik, Group Chief Financial Officer
- Abhitesh  Kumar, Chief Growth Officer

---
Source: rupiya.io/stocks/entero
Disclaimer: For research and education only. Not investment advice.